Innovation and Commercialization Office

Our goal is to actively grow the culture of innovation and commercialization in the Cumming School of Medicine.

Our Team

Dr. Aaron Phillips, PhD - Associate Dean of Commercialization

Dr. Aaron Phillips, PhD - Associate Dean of Commercialization

   Elsa Reisenhofer, Commercialization Ecosystem Lead

Elsa Reisenhofer, MBT - Commercialization Ecosystem Lead

Who We Support

We support a wide range of innovators connected to the Cumming School of Medicine (CSM), including:

  • Students, Staff, and Faculty affiliated with CSM
  • UCalgary Researchers engaged in human health research (with a focus on CSM-affiliated initiatives)

Whether you're exploring an early-stage idea or advancing a validated innovation, we help you navigate the complex pathway of commercialization.

Resources We Offer

  • Ecosystem Navigation: Access to our database and calendar of commercialization ecosystem resources curated for health science research: including accelerators, mentors, IP support, clinical collaborators, and funding programs.
  • Stay Inspired & Informed: Subscribe to our CSM Innovation Newsletter for key dates, opportunities, and real stories of success within our medical innovation community.
  • Personalized Commercialization Connections: Complete a Commercialization Interest Disclosure to help us offer you precision support from targeted introductions to VC firms and industry partners to matchmaking with translational funding opportunities.
  • Grants: This upcoming 10-20K Proof and Propel Grant will support CSM commercialization efforts from an early stage idea to an advanced validated innovation. The goal of this grant is to catalyze the efforts of CSM staff, students or faculty by providing targeted funding to help bridge the gap between research and market impact. (More details coming soon!)

Help Us Help You

Tell us a little about your commercialization interests to help us offer you precision support, from targeted introductions to VC firms and industry partners, to matchmaking with translational funding opportunities.